At SheSparks, Geetha Manjunath, Founder & CEO of NIRAMAI Health Analytix spoke about Thermalytix, an AI-based medical device for breast cancer screening.
The article from YourStory highlights the journey of Geetha Manjunath, who founded Niramai, a company focused on revolutionizing breast cancer detection through AI. After losing her mother to breast cancer, Geetha was driven to address the limitations of traditional mammography, particularly its ineffectiveness in dense breast tissue and its radiation exposure. Niramai developed a non-invasive, radiation-free, and cost-effective AI-based solution called Thermalytix, which uses thermal imaging to detect early signs of breast cancer. This technology not only aims to make breast cancer screening more accessible and less painful but also addresses the cultural sensitivities around breast examination in India. The device has shown promising results with high sensitivity and specificity, and Niramai has expanded its reach through partnerships with hospitals and clinics, aiming to reduce the mortality rate from breast cancer by enabling early detection.